Joel S. Schuman, MD, is the Elaine Langone Professor and Vice Chair for Research in the Department of Ophthalmology and Professor of Neuroscience & Physiology at NYU Langone Health, NYU Grossman School of Medicine. He is Professor of Biomedical Engineering and Electrical & Computer Engineering at NYU Tandon School of Engineering and Professor of Neural Science in the Center for Neural Science at NYU College of Arts and Sciences. He chaired the ophthalmology department at NYU Langone Health, NYU Grossman School of Medicine from 2016-2020. Prior to arriving at NYU in 2016, he was the Eye and Ear Foundation Professor and Chairman of Ophthalmology (2003-2016), the Eye and Ear Institute, University of Pittsburgh School of Medicine and Director of the University of Pittsburgh Medical Center Eye Center, Professor of Bioengineering at the Swanson School of Engineering, University of Pittsburgh and Founder of the Louis J. Fox Center for Vision Restoration of the University of Pittsburgh Medical Center and the University of Pittsburgh. He was a member of the McGowan Institute for Regenerative Medicine and the Center for the Neural Basis of Cognition, Carnegie Mellon University, and University of Pittsburgh. Dr. Schuman is a native of Roslyn, New York; he graduated Columbia University (AB, 1980) and Mt. Sinai School of Medicine (MD, 1984). Following his internship at New York's Beth Israel Medical Center (1985), he completed residency training at the Medical College of Virginia (1988) and a glaucoma fellowship at Massachusetts Eye & Ear Infirmary (clinical 1989; research 1990), where he was a Heed Fellow. After just over 1 year on the Harvard faculty, he moved to New England Medical Center, Tufts University to cofound the New England Eye Center in 1991, where he was Residency Director (1991-1999) and Glaucoma and Cataract Service Chief (1991-2003). He became a Professor of Ophthalmology in 1998 and Vice Chair in 2001. Dr. Schuman and his colleagues were first to identify a molecular marker for human glaucoma, published in Nature Medicine in 2001. Continuously funded by the National Eye Institute as a principal investigator since 1995, he is an inventor of optical coherence tomography (OCT), used world-wide for ocular diagnostics. Dr. Schuman has published more than 400 peer-reviewed scientific journal articles, has authored or edited 8 books, and has contributed more than 80 book chapters. Dr. Schuman is a founding member of the Association for Research in Vision and Ophthalmology (ARVO) Multidisciplinary Ophthalmic Imaging (MOI) cross-sectional group, served on the program committee from its founding and chaired the MOI program committee from 2007-2013. He is also a founder and cochair of ARVO Imaging (formerly ARVO/ISIE, The International Society for Imaging in the Eye, inaugurated 2002). Dr. Schuman was cochair of the International Glaucoma Symposium from 1998-2007, the world's largest meeting devoted to glaucoma, which merged with the World Glaucoma Congress in 2007, for which he was Program cochair from 2007-2011. He chaired the Hawaiian Eye meeting glaucoma section from 1993-2019. In 2002, he received the Alcon Research Institute Award and the Lewis Rudin Glaucoma Prize; in 2003, the Senior Achievement Award from the American Academy of Ophthalmology (AAO); in 2004, he was elected into the American Society for Clinical Investigation; in 2006, he received the ARVO Translational Research Award; and in 2012, the Carnegie Science Center Award as well as sharing the Champalimaud Award (a 1 million Euro cash prize). He was elected to the American Ophthalmological Society in 2008. In 2011, Dr. Schuman was the Clinician-Scientist Lecturer of the American Glaucoma Society. In 2012, he received the Carnegie Science Center's Award in Life Sciences. In 2013, he gave the Robert N. Shaffer Lecture at the American AAO Annual Meeting and received the AAO Lifetime Achievement Award. In 2014, he became a Gold Fellow of ARVO, and he received a Spe